4YS9

Ataxin-3 Carboxy-Terminal Region - Crystal C1 (tetragonal)

  • Classification: TRANSCRIPTION
  • Organism(s): Escherichia coli, Homo sapiens
  • Expression System: Escherichia coli BL21(DE3)
  • Mutation(s): No 

  • Deposited: 2015-03-16 Released: 2016-03-09 
  • Deposition Author(s): Zhemkov, V.A., Kim, M.
  • Funding Organization(s): National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS), Russian Ministry of Science, Russian Scientific Fund, Russian Ministry of Education and Science, National Ataxia Foundation

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.207 
  • R-Value Observed: 0.208 

wwPDB Validation   3D Report Full Report


This is version 2.1 of the entry. See complete history


Literature

The 2.2-Angstrom resolution crystal structure of the carboxy-terminal region of ataxin-3.

Zhemkov, V.A.Kulminskaya, A.A.Bezprozvanny, I.B.Kim, M.

(2016) FEBS Open Bio 6: 168-178

  • DOI: https://doi.org/10.1002/2211-5463.12029
  • Primary Citation of Related Structures:  
    4WTH, 4YS9

  • PubMed Abstract: 

    An expansion of polyglutamine (polyQ) sequence in ataxin-3 protein causes spinocerebellar ataxia type 3, an inherited neurodegenerative disorder. The crystal structure of the polyQ-containing carboxy-terminal fragment of human ataxin-3 was solved at 2.2-Å resolution. The Atxn3 carboxy-terminal fragment including 14 glutamine residues adopts both random coil and α-helical conformations in the crystal structure. The polyQ sequence in α-helical structure is stabilized by intrahelical hydrogen bonds mediated by glutamine side chains. The intrahelical hydrogen-bond interactions between glutamine side chains along the axis of the polyQ α-helix stabilize the secondary structure. Analysis of this structure furthers our understanding of the polyQ-structural characteristics that likely underlie the pathogenesis of polyQ-expansion disorders.


  • Organizational Affiliation

    Laboratory of Molecular Neurodegeneration St Petersburg State Polytechnical University Russia; Laboratory of Enzymology National Research Center «Kurchatov Institute»B.P. Konstantinov Petersburg Nuclear Physics Institute Gatchina Russia.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Maltose-binding periplasmic protein, Ataxin-3 chimeraA [auth B]441Escherichia coliHomo sapiensMutation(s): 0 
Gene Names: malEZ5632ECs5017ATXN3ATX3MJDMJD1SCA3
UniProt & NIH Common Fund Data Resources
Find proteins for P54252 (Homo sapiens)
Explore P54252 
Go to UniProtKB:  P54252
PHAROS:  P54252
GTEx:  ENSG00000066427 
Find proteins for P0AEY0 (Escherichia coli O157:H7)
Explore P0AEY0 
Go to UniProtKB:  P0AEY0
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP0AEY0P54252
Sequence Annotations
Expand
  • Reference Sequence
Oligosaccharides

Help

Entity ID: 2
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranoseB [auth A]2N/A
Glycosylation Resources
GlyTouCan:  G07411ON
GlyCosmos:  G07411ON
Biologically Interesting Molecules (External Reference) 1 Unique
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.207 
  • R-Value Observed: 0.208 
  • Space Group: P 41
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 59.67α = 90
b = 59.67β = 90
c = 135.165γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data collection
HKL-2000data scaling
Cootmodel building
PHASERphasing
HKL-2000data reduction
SCALEPACKdata scaling

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United StatesR01NS074376
National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United StatesR01NS056224
Russian Ministry of ScienceRussian Federation11.G34.31.0056
Russian Scientific FundRussian Federation14-25-00024
Russian Ministry of Education and ScienceRussian Federation17.1360.2014/K
National Ataxia FoundationUnited StatesTranslational Award

Revision History  (Full details and data files)

  • Version 1.0: 2016-03-09
    Type: Initial release
  • Version 1.1: 2016-03-16
    Changes: Database references
  • Version 1.2: 2017-09-06
    Changes: Author supporting evidence, Derived calculations
  • Version 1.3: 2017-11-22
    Changes: Refinement description
  • Version 1.4: 2018-04-18
    Changes: Data collection, Database references
  • Version 1.5: 2019-12-18
    Changes: Author supporting evidence
  • Version 2.0: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Atomic model, Data collection, Derived calculations, Non-polymer description, Structure summary
  • Version 2.1: 2023-09-27
    Changes: Data collection, Database references, Refinement description, Structure summary